Miconazole 2%, Chlorhexidene Gluconate 2%

Verify with FDA CVM →

22 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Miconazole 2%, Chlorhexidene Gluconate 2%

Administration Routes

TopicalUnknown

Species Affected

Dog 20
Cat 2

Most Affected Breeds

Retriever - Labrador 3
American Pit Bull Terrier 3
Bulldog - French 3
Chihuahua 2
Dog (other) 2
Dachshund - Standard Smooth-haired 1
Dachshund - Standard Long-haired 1
Mastiff 1
Boxer (German Boxer) 1
Domestic Shorthair 1

Most Reported Reactions

Application site reddening 6
Reddening of the skin 5
Skin textural change 3
Lack of efficacy - NOS 3
Crust 2
Low platelet count 2
Large platelets 2
Platelet disorder NOS 2
Increased band neutrophilia 2
Lymphocytosis 2
Monocytosis 2
Elevated symmetrical dimethylarginine (SDMA) 2

Outcome Breakdown

Recovered/Normal
12 (54.5%)
Outcome Unknown
10 (45.5%)

Data Summary

Metric Value
Total adverse event reports 22
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 14
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Miconazole 2%, Chlorhexidene Gluconate 2% Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 22 adverse event reports referencing Miconazole 2%, Chlorhexidene Gluconate 2%, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Miconazole 2%, Chlorhexidene Gluconate 2%. Reported administration routes include Topical, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Miconazole 2%, Chlorhexidene Gluconate 2% reports are Dog (20 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (3), American Pit Bull Terrier (3), Bulldog - French (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Miconazole 2%, Chlorhexidene Gluconate 2% are Application site reddening (6), Reddening of the skin (5), Skin textural change (3), Lack of efficacy - NOS (3). Of the 22 reports with a coded outcome, Recovered/Normal is the leading category at 54.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Miconazole 2%, Chlorhexidene Gluconate 2%.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial